Neoplasms, Colorectal Terminated Phase 2 Trials for Cetuximab (DB00002)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00321100Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without BevacizumabTreatment